Erratum: A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells

類似資料

• A TLR7 agonist enhances the antitumor efficacy of obinutuzumab in murine lymphoma models via NK cells and CD4 T cells
  著者:: Cheadle, E J, 等
  出版事項: (2017)
• Antitumor efficacy of radiation plus immunotherapy depends upon dendritic cell activation of effector CDS(+) T cells
  著者:: Dovedi, Simon J., 等
  出版事項: (2016)
• Novel TLR7 agonist stimulates activity of CIK/NK immunological effector cells to enhance antitumor cytotoxicity
  著者:: Gao, Dong, 等
  出版事項: (2018)
• Pathogen-like Nanoassemblies of Covalently Linked TLR Agonists Enhance CD8 and NK Cell-Mediated Antitumor Immunity
  著者:: Manna, Saikat, 等
  出版事項: (2020)
• The antitumor immune response generated by fractionated radiation therapy may be limited by tumor cell adaptive resistance and can be circumvented by PD-L1 blockade
  著者:: Dovedi, S J, 等
  出版事項: (2015)